Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-94 |
filingDate |
2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca08ced1083c8e45645be98144316ceb |
publicationDate |
2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6921773-B2 |
titleOfInvention |
Use of α-1AR subtype-selective drugs in patients with acute myocardial infarction |
abstract |
The present invention relates to the use of α 1a AR-selective and/or α 1a /α 1d -selective antagonists in a method of preventing restenosis after myocardial infarction and re-perfusion. The invention further relates to a method of identifying agents suitable for us in such a method. |
priorityDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |